VALUE DEMONSTRATION OF IMMUNO-ONCOLOGY THERAPIES IN A RARE TUMOR COMPARING ASCO, NCCN, AND TRADITIONAL COST-EFFECTIVENESS ANALYSIS

Garmo, V; Ambavane, A; Lanitis, T; Kongnakom, T; Phatak, H

VALUE IN HEALTH, 2017; 20 (5): A109